Predicting survival of patients with metastatic epidural spinal cord compression from cancer of the head-and-neck

Dirk Rades, Steven E. Schild, Johann H. Karstens, Samer G. Hakim

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Patients and Methods: In 58 patients, eleven factors were evaluated for influence on survival: age, gender, performance status, tumor site, time from cancer diagnosis until MESCC, affected vertebrae, walking ability, further osseous lesions, organ metastases, time developing motor deficits and radiation regimen. Factors with significant association with survival or a trend (multivariate analysis) were used for scoring.

Results: Walking ability, visceral metastases and time to developing motor deficits were included in the score. Scoring points were calculated by dividing 6-month survival rates by 10. Patients' scores were obtained from adding the points of the three factors. Four groups were created, 7-10, 12-15, 16-18 and 21 points. Six-month survival rates were 0%, 27%, 71% and 100% (p<0.001).

Conclusion: With this new instrument, one can estimate 6-month survival probabilities of patients with MESCC from head-and-neck cancer.

Aim: To develop an instrument for estimating survival after irradiation for metastatic epidural spinal cord compression (MESCC) from head and neck cancer.

Original languageEnglish (US)
Pages (from-to)385-388
Number of pages4
JournalAnticancer Research
Volume35
Issue number1
StatePublished - Jan 1 2015

Fingerprint

Spinal Cord Compression
Head and Neck Neoplasms
Survival
Walking
Survival Rate
Neoplasm Metastasis
Neoplasms
Spine
Multivariate Analysis
Radiation

Keywords

  • Head-and-neck cancer
  • Irradiation
  • Metastatic epidural spinal cord compression
  • Predictive instrument
  • Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Predicting survival of patients with metastatic epidural spinal cord compression from cancer of the head-and-neck. / Rades, Dirk; Schild, Steven E.; Karstens, Johann H.; Hakim, Samer G.

In: Anticancer Research, Vol. 35, No. 1, 01.01.2015, p. 385-388.

Research output: Contribution to journalArticle

Rades, Dirk ; Schild, Steven E. ; Karstens, Johann H. ; Hakim, Samer G. / Predicting survival of patients with metastatic epidural spinal cord compression from cancer of the head-and-neck. In: Anticancer Research. 2015 ; Vol. 35, No. 1. pp. 385-388.
@article{dcc812115f424d2e9ea9923f9dd78b61,
title = "Predicting survival of patients with metastatic epidural spinal cord compression from cancer of the head-and-neck",
abstract = "Patients and Methods: In 58 patients, eleven factors were evaluated for influence on survival: age, gender, performance status, tumor site, time from cancer diagnosis until MESCC, affected vertebrae, walking ability, further osseous lesions, organ metastases, time developing motor deficits and radiation regimen. Factors with significant association with survival or a trend (multivariate analysis) were used for scoring.Results: Walking ability, visceral metastases and time to developing motor deficits were included in the score. Scoring points were calculated by dividing 6-month survival rates by 10. Patients' scores were obtained from adding the points of the three factors. Four groups were created, 7-10, 12-15, 16-18 and 21 points. Six-month survival rates were 0{\%}, 27{\%}, 71{\%} and 100{\%} (p<0.001).Conclusion: With this new instrument, one can estimate 6-month survival probabilities of patients with MESCC from head-and-neck cancer.Aim: To develop an instrument for estimating survival after irradiation for metastatic epidural spinal cord compression (MESCC) from head and neck cancer.",
keywords = "Head-and-neck cancer, Irradiation, Metastatic epidural spinal cord compression, Predictive instrument, Survival",
author = "Dirk Rades and Schild, {Steven E.} and Karstens, {Johann H.} and Hakim, {Samer G.}",
year = "2015",
month = "1",
day = "1",
language = "English (US)",
volume = "35",
pages = "385--388",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - Predicting survival of patients with metastatic epidural spinal cord compression from cancer of the head-and-neck

AU - Rades, Dirk

AU - Schild, Steven E.

AU - Karstens, Johann H.

AU - Hakim, Samer G.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Patients and Methods: In 58 patients, eleven factors were evaluated for influence on survival: age, gender, performance status, tumor site, time from cancer diagnosis until MESCC, affected vertebrae, walking ability, further osseous lesions, organ metastases, time developing motor deficits and radiation regimen. Factors with significant association with survival or a trend (multivariate analysis) were used for scoring.Results: Walking ability, visceral metastases and time to developing motor deficits were included in the score. Scoring points were calculated by dividing 6-month survival rates by 10. Patients' scores were obtained from adding the points of the three factors. Four groups were created, 7-10, 12-15, 16-18 and 21 points. Six-month survival rates were 0%, 27%, 71% and 100% (p<0.001).Conclusion: With this new instrument, one can estimate 6-month survival probabilities of patients with MESCC from head-and-neck cancer.Aim: To develop an instrument for estimating survival after irradiation for metastatic epidural spinal cord compression (MESCC) from head and neck cancer.

AB - Patients and Methods: In 58 patients, eleven factors were evaluated for influence on survival: age, gender, performance status, tumor site, time from cancer diagnosis until MESCC, affected vertebrae, walking ability, further osseous lesions, organ metastases, time developing motor deficits and radiation regimen. Factors with significant association with survival or a trend (multivariate analysis) were used for scoring.Results: Walking ability, visceral metastases and time to developing motor deficits were included in the score. Scoring points were calculated by dividing 6-month survival rates by 10. Patients' scores were obtained from adding the points of the three factors. Four groups were created, 7-10, 12-15, 16-18 and 21 points. Six-month survival rates were 0%, 27%, 71% and 100% (p<0.001).Conclusion: With this new instrument, one can estimate 6-month survival probabilities of patients with MESCC from head-and-neck cancer.Aim: To develop an instrument for estimating survival after irradiation for metastatic epidural spinal cord compression (MESCC) from head and neck cancer.

KW - Head-and-neck cancer

KW - Irradiation

KW - Metastatic epidural spinal cord compression

KW - Predictive instrument

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84920504932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920504932&partnerID=8YFLogxK

M3 - Article

C2 - 25550576

AN - SCOPUS:84920504932

VL - 35

SP - 385

EP - 388

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1

ER -